A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Novartis
Novartis
Mayo Clinic
Massive Bio, Inc.
Incyte Corporation
University of Wisconsin, Madison
Barbara Ann Karmanos Cancer Institute
Stanford University
BerGenBio ASA
University Hospital, Basel, Switzerland
Sumitomo Pharma America, Inc.
Rutgers, The State University of New Jersey
Northwestern University
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Celgene
Vanderbilt-Ingram Cancer Center
CureOne
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Rutgers, The State University of New Jersey
Barbara Ann Karmanos Cancer Institute
Stanford University
City of Hope Medical Center
Rutgers, The State University of New Jersey
Vanderbilt University
Indiana University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of South Florida
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
Asan Medical Center
Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Tufts Medical Center
Roswell Park Cancer Institute
City of Hope Medical Center
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center